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Like humans, outbred Sprague-Dawley CD rats exhibit a polygenic pattern of inheritance
of the obese phenotype and not all individuals exposed to a high calorie intake develop
obesity. We hypothesized that differences in gut microbiota composition account for
phenotype differences between obese prone (OP) and obese resistant (OR) rats. We
studied the gut microbiota composition of OPand OR rats after a high fat (HF) diet and
how they respond to fermentation of resistant starch (RS). In phase 1 of the study 28
OP and 28 OR rats were fed a HF diet. In order to determine causal role of microbiota
on phenotypes, In phase 2, a microbiota transplant between the two phenotypes
was performed before switching all rats to a HF diet supplemented with 20% RS.
We determined microbiota composition by 16S sequencing and predicted microbiota
function by PICRUSt2. Despite a similar calorie intake, in phase 2 OP rats gained more
weight and accumulated more abdominal fat in both phase 1 and 2 compared to OR
rats (P < 0.001; n = 6). The OP rats fermented RS more robustly compared with OR
rats with an increase in total bacteria, short chain fatty acids, and increased weight of
the cecum, but microbiota of OP rats had much lower alpha diversity and evenness.
The microbiota of OP rats, had higher amounts of bacteria from order Bacteroidales,
specifically family Muribaculaceae (S24-7), which is known to possess several starch
degrading enzymes and was reported in previous studies to increase with fermentation
of RS. The OR rats fermented RS less but had higher bacterial diversity and evenness
and had significantly higher bacterial counts from phylum Firmicutes particularly order
Clostridiales, genus Clostridium and an uncultured bacterium of the genus Akkermansia.
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The microbiota of OR rats had enhanced bacterial chemotaxis, phosphotransferase
system (PTS), and fatty acid biosynthesis compared to OP rats whose microbiota had
higher glycan degradation and LPS biosynthesis pathways. The microbiota transplant
did not change obesity phenotype or microbiota composition. In conclusion, a higher
alpha-diversity and evenness of the microbiota and higher proportions of Clostridiales
and Akkermansia in OR rats were associated with a better metabolic phenotype with
lower body fat. However, robust RS fermentation caused a lower diversity and evenness
and did not result in a leaner phenotype.
Keywords: obese prone, obese resistant, microbiota, resistant starch, fermentation

INTRODUCTION

in causation of the obese phenotype is minimal. It is possible
that variations in specific bacterial species rather than phylum
level changes are more important. For example, more recent
studies have shown that some genera among Firmicutes impact
host obesity phenotype by acting through the intestinal immune
system. Specifically, abundance of class Clostridia increases IgA
secretion, host lipid absorption by modulating the expression of
CD36 a protein involved the transport and absorption of fat in the
small intestines, and overall intestinal immune phenotype (6).
The gut microbiota of obese humans and animals are
characterized by reduced species richness and diversity and
this may impact metabolic capacity (1, 2). Maintenance of
diversity and collective functional capacity of the microbiota is
important for optimal health. The richness and diversity of the
gut microbiota in OP and OR rats have not been evaluated.
We hypothesized that differences in the obesity phenotype may
be attributed to the microbiota composition, differences in
the richness, and overall diversity of bacterial species and in
metabolic function of the bacteria. Herein we report findings
from a feeding study that includes a HF diet and a HF diet
supplemented with resistant starch and a fecal transplant between
the two phenotypes (Figure 1). Prior to the transplant, we tested
the efficacy of two antibiotic formulations and MiraLAX R in
reducing the gut bacterial load in the recipient rats to create
a niche for the probiotic bacteria to establish effectively (7).
MiraLAX R is an over-the-counter colonoscopy preparation
that knocks down bacterial loads in the lower gut (8). We
compared its efficacy to that of the antibiotics in creating a
niche for the probiotic bacteria transplant. We report on the
effects of diet, antibiotics, MiraLAX R and the transplant on
microbiota composition, alpha diversity, beta diversity, and
microbial function in relation to the obesity phenotype.

Several studies have consistently shown that variations in
bacterial types in the gut microbiota are associated with
host phenotype: obese or lean. While causal implication of
specific bacterial species to obesity is not clear, variation in
the composition of the gut microbiota has been demonstrated
(1, 2). The gut microbiota influences host phenotype through
direct contact with intestinal cells or indirectly through bacterial
metabolites that impact cellular mechanisms. We chose to study
the microbiota composition of outbred Sprague-Dawley CD rats
because they mimic the human obese phenotype in terms of a
polygenic pattern of inheritance. Like humans, when these rats
are exposed to excess energy with a high fat diet, not all of them
develop obesity. The obesity-resistant rats (OR) retain a leaner
frame while the obesity-prone (OP) rapidly gain weight within 4
weeks when fed the same high fat (HF) diet (3, 4). Because leptin
production and receptor sensing in these rats is not impaired,
they do not display extreme endocrine disturbances such as those
in db/db mice or the Zucker diabetic fatty rats.
In addition to responding differently to a HF diet, we have
previously shown that the OP and OR rats respond differently to
dietary resistant starch (RS) with the OP fermenting RS robustly
while the OR minimally ferment (5). However, fermentation by
OP or OR rats did not result in greater body fat when compared
to the OP or OR rats fed the same diets except without resistant
starch (5). Thus, dietary fiber fermentation products such as
short chain fatty acids (SFCA) may not be a contributary factor
in the ability of OR rats to resist fat accumulation. The robust
fermentation in OP rats is accompanied by increases in the
family Muribaculaceae (previously known as S24-7), and the
archaea Methanobrevibacter smithii, which are both markers of
fermentation of RS (5).
Studies examining the role of the gut microbiota in relation
to obesity have consistently shown a lower relative abundance of
phylum Bacteroidetes and a higher relative abundance of phylum
Firmicutes in obese mice and humans compared to lean subjects
(1, 2). However, knowledge on the role of specific bacterial species

MATERIALS AND METHODS
Animals and Study Plan
The study was approved by the Louisiana State University
Institutional Animal Care and Use Committee (IACUC) as 15–
109. After 1 week of quarantine, 4-week-old male 28 OP and
28 OR rats (Charles River Laboratories) were singly housed in a
temperature-controlled vivarium with a 12:12-h light/dark cycle
and acclimated to a powdered low-fat diet for a week.

Abbreviations: AIN-93, American Institute of Nutrition-1993; CD, Cesarean
derived; EBW, Emboweled body weight; HF, High Fat; HOMA-IR, Homeostatic
model of assessment of insulin resistance; LF, Low Fat; LX, Miralax R ; NA,
Neomycin, and ampicillin; OP, Obesity Prone; OR, Obesity Resistant; RS, Resistant
Starch; VM, Vancomycin and meropenem; WA, Water.

Frontiers in Nutrition | www.frontiersin.org

2

December 2021 | Volume 8 | Article 746515

Obanda et al.

Gut Microbiota and Obesity Phenotype

FIGURE 1 | Flow diagram of the Experimental design.

(9). Cecal contents of the 8 rats euthanized were collected by
tying off the cecum before removal from the GI tract aseptically
and aerobically in a hood blowing filtered air, diluted 1:10 with
sterile 15% glycerol/PBS solution. The diluted cecal contents
from the four OP rats were pooled into one sample and those
from the four OR rats were also pooled into one sample and
stored at −80◦ C.

TABLE 1 | Diets for obesity prone and obesity resistant rats.
Diet components
Ingredients (g)

Phase 1 diet

Phase 2 diet

Energy value (Kcal/g)

HF (g)

HF-RS (g)

a

AMIOCATM starch

3.5

405.7

31.8

b

HI-MAIZE® 260 RS

2.8

0

472.4

Sucrose

4.0

100

100

Casein

3.50

140

140

Cellulose

0

106.2

7.7

Corn oil

8.84

100

100

Lard

9.00

100

100

Mineral mix (AIN-93M)

0.88

35

35

Vitamin mix (AIN 93)

3.87

10

10

Choline chloride

0

1.3

1.3

L-Cystine

4

1.8

1.8

Total weight (Kcal)

Phase 2 Procedures
The remaining 24 OP and 24 OR rats were separately divided
into 4 sub-groups of 6 each stratified using body weight and
HOMA-IR. A sample size of n = 6 for each group was used based
on a power analysis in a previous resistant starch fermentation
study that showed 6 to be sufficient to attain a statistical power
of 0.90 for a one tailed test and 8 samples for a two tailed
test (10). Fresh fecal samples were collected from under the
feeding cages for bacterial load determination prior to a knock
down treatment.
The knockdown and transplant treatments performed
separately for OP and OR rats were as shown below:

1,000 (4182.5) 1,000 (4182.7)

a AMIOCATM

is a 100% amylopectin cornstarch product from Ingredion (Bridgewater, NJ).
260 is high-amylose cornstarch from Ingredion Incorporated (Bridgewater,
NJ). The batch used was 42.3% resistant starch based on wet weight for use in diet.

b HI-MAIZE®

1. Sub-group 1-broad-spectrum antibiotics neomycin +
ampicillin (NA) at a dose of 55 mg/kg/day for neomycin and
110 mg/kg/day for ampicillin by gavage once daily for 3 days.
2. Sub-group 2-one narrow-spectrum and one broad-spectrum
antibiotic: vancomycin and meropenem (VM) both at a dose
of 50 mg/kg/day by gavage once daily for 3 days.
3. Sub-group 3: MiraLAX R (LX) a colonoscopy preparation
tested as an alternative to antibiotics. After a water gavage for 2
days, MiraLAX R was given on the 3rd day in two gavages 3 h
apart at a dose of 63 mg in 437 ul for a 250 g rat calculated
based on a human dose of 17 g dissolved in 4–8 ounces for
a 150-lb. person. All other groups were given an additional
gavage of water to match the stress of an additional gavage in
the MiraLAX group.
4. Sub-group 4: gavaged with water (WA) as control treatment
once daily for 2 days and twice on the third day.

Phase 1 Procedures
Rats were fasted (∼6 h) before blood collection by retro-orbital
bleeding to determine serum glucose and insulin levels for
calculation of the homeostatic model of assessment of insulin
resistance index (HOMA-IR). A flow diagram of the study design
is shown in Figure 1. All OP and OR rats were then fed the HF
diet for 4 weeks (phase 1). Food and water were provided ad
libitum. Body weight and food intake were determined twice a
week. The composition and energy value of the HF diets is shown
in Table 1.
After feeding all rats a HF diet in phase 1, four OP, and four
OR rats were euthanized for determination of abdominal body
fat accumulation and collection of cecal contents as inoculum
for the transplant. Procedures for euthanasia, collection and
processing of tissues are similar to those shown in Obanda et al.

Frontiers in Nutrition | www.frontiersin.org
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concentrations of amplicon standard DNA were converted into
gene copies per gram cecal contents as shown in Obanda et al. (9).

After knock-down treatments, rats had free access to HF diet and
water for 2 days. Fresh fecal samples were collected from under
the feeding cages within 24 h after knockdown treatments.
Three days after knockdown, each of the OP rats was gavaged
with one ml aliquot of cecal contents pooled from 4 donor
OR rats. Similarly, each of the OR rats was gavaged with one
ml of contents pooled from 4 donor OP rats. Rats given water
as control for knock-down again received water as transplant
control. After transplants, the rats were switched to the high
fat diet containing resistant starch (HF-RS) and fed ad libitum.
The composition and energy value of the HF-RS diet is shown
in Table 1. It was formulated to contain 20% high-amylose
cornstarch (HI-MAIZE R 260 RS) by weight and was isocaloric to
the HF diet. AMIOCATM powder corn starch has 100% digestible
amylopectin. Food uptake and body weight were monitored for
another 4 weeks.

16S rRNA Gene Sequencing
Amplification, sequencing, and bioinformatics of bacterial DNA
from phase 2 were performed at the LSU Microbial Genomics
Resource Group. Briefly, the 16S rRNA gene hypervariable region
V4 in 20 ng of DNA was amplified using gene-specific primers
were F:5′ TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG
GTGCCAGCMGCCGCGGTAA3′ R:5′ GTCTCGTGGGCTCG
GAGATGTGTATAAGAGACAGGGACTACHVGGGTWTCT
AAT 3′ as shown in Walters et al. (12). PCR conditions were
95◦ C for 3 min, 25 cycles of 95◦ C for 30 s, 55◦ C for 30 s and
72◦ C for 30 s, 72◦ C for 5 min and holding at 4◦ C. Two steps of
amplification were performed to prepare the sequencing library
using AccuPrime Taq high fidelity DNA polymerase system
(Invitrogen). A negative control from DNA extraction and a
positive control from Microbial Mock Community HM-276D
(BEI Resources) were included during library preparation. PCR
products were purified using AMPure XP beads. Two µl of
purified amplicon DNA was amplified for 8 cycles with the same
PCR conditions using primers with different molecular barcodes:
forward 5′ AATGATACGGCGACCACCGAGATCTACAC
(i5) TCGTCGGCAGCGTC 3′ ; reverse 5′ CAAGCAGAAGA
CGGCATACGAGAT (i7) GTCTCGTGGGCTCGG 3′ . Expected
amplicon length is ∼290–294 bp including the specific primer.
The indexed amplicon libraries were purified using AMPure
XP beads, quantified by Quant-iT PicoGreen (Invitrogen) and
pooled together. The pooled library was quantified using a KAPA
Library Quantification Kit (Kapa Biosystems), diluted, and
denatured as per the guideline of the Illumina MiSeq sequencing
library preparation. Paired-end sequencing (2 × 250 bp) was
performed on a MiSeq (Illumina) using MiSeq Reagent Kit
v2 (500-cycles).

Euthanasia and Collection of Tissues
After 4 weeks of phase 2, rats were euthanized by isoflurane
inhalation. Excised retroperitoneal, perirenal, and epidydimal fat
pads were used to determine total abdominal fat weight. The
weight of the gastrointestinal tract without contents was added
to the disemboweled body weight to obtain the emboweled body
weight (EBW). Cecal contents were snap frozen in liquid nitrogen
and stored at −80◦ C.

Bacterial DNA Extraction and
Quantification of 16S rRNA Gene Copies by
QPCR
Genomic DNA from fecal samples and cecal contents was
extracted using the QIAamp DNA stool MiniKit (Qiagen,
Valencia, CA) with a modified method including a bead-beating
process. About 180–220 mg of each sample was mixed with 0.2 g
zirconia/silica beads (diameter: 0.1 mm, Biospec) and lysis buffer.
RNase A was added to remove RNA before passing the eluate
through a concentration column. Quality and concentration of
the purified DNA were determined using a NanoDrop 1000.
Isolated DNA was stored at −20◦ C and used for 16S amplicon
library preparation or qPCR.
To quantify the 16S gene in fecal contents, the universal
primers F:5′ ACGTCRTCCMCNCCTTCCTC3′ and R:5′ GTG
STGCAYGGYYGTCGTCA3′ targeting the V2-V3 regions of the
16S gene as shown before in Belenguer et al. (11), were prepared
by Integrated DNA Technologies (Coralville, Iowa). The Basic
Local Alignment Search Tool (https://blast.ncbi.nlm.nih.gov/
Blast.cgi, accessed June 26th, 2017, was used to verify in silico
that these primers for the universal 16S rRNA gene matched a
broad range of bacteria. The SYBR Green qPCR assay was used
to quantify the 16S gene on the ABI Prism 7900HT Sequence
Detection System (Life Technologies, Foster City, California).
Cycling conditions were 50◦ C for 2 min, 95◦ C for 10 min, and
40 cycles of 95◦ C for 15 s, followed by primer annealing at 60◦ C
and a final 78◦ C for 30 s. Amplicon quantities (gene copies per
microliter) vs. cycles-to-quantification standard curves were used
to determine total bacteria (16S rRNA gene) quantities. Molar

Frontiers in Nutrition | www.frontiersin.org

16S rRNA Gene Amplicon Sequencing
Analysis
Fastq files from the Illumina MiSeq run were processed through
the QIIME2 pipeline as shown by Bolyen et al. (13) using the
DADA2 plugin (14) to determine amplicon sequence variants
(ASVs). ASVs are a collection of exact sequences having a defined
statistical confidence and are generated without clustering or
reference databases. Quality control and trimming of raw reads
were performed with parameters set based on quality profiles
of the sequencing run to retain high quality data and trim off
amplicon primers. The DADA2 algorithm requires a uniform
truncation length across all reads and was used to build an
error profile for the samples. Quality scores were above 25 until
the last 10 bp so forward and reverse reads were truncated
at length 240 bp and primer sites were removed. Forward
and reverse reads were merged to produce full amplicons and
resulting amplicons outside of the expected 250–254 bp range
were filtered out followed by chimera detection and removal
as detailed in Callahan et al. (14). Data was rarefied to a
sampling depth of 10,000 reads per sample. Any ASVs that
appeared in only one sample were removed and the remaining
ones were aligned using mafft and a phylogenetic tree was
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analysis of alpha and beta-diversity was determined with a variety
of tests in QIIME2: the multiway Adonis test of differentiation
among microbiota based on location and spread of samples
followed by Permdisp to determine pairwise dispersion (spread
of samples) and pairwise tests for differentiation in centroid
location (Permanova) after 999 permutations. The Spearman and
Pearson correlations were performed between ECW and diversity
or relative abundance of particular taxa using the QIIME2 output.
The relative abundance values of different taxa were converted
to percentages.

built with FastTree. Taxonomic classification was performed
using the SILVA v138 database (15). We performed multivariate
testing between treatment groups and further performed posthoc comparisons when significant differences were observed. We
determined alpha diversity indices: ASV’s (a count of unique
ASV’s in each sample), Pielou’s evenness (a measure of how close
in numbers the species in a community are), Shannon diversity
(to account for both abundance and evenness of the sequence
variants present), and Faith pd which uses phylogenetic distance
(branch length of tree) to calculate the diversity in an individual
sample. Beta diversity was calculated based on the weighted
unifrac distance metric and visualized using principal component
analysis (PCA) as implemented in QIIME2.

RESULTS
Energy Intake, Body Weight, Body Fat, and
Fermentation Variables

Linear Discriminant Analysis
Using the Galaxy online workflow application (https://
huttenhower.sph.harvard.edu/galaxy), we determined the
taxa most likely to explain differences between the OP and OR
rats using linear discriminant analysis (LDA) effect size (LEfSe).
LEfSe utilizes a non-parametric Kruskal-Wallis rank sum test to
assess differential features with significantly different abundances
between assigned taxa and performs LDA to estimate the effect
size of each sequence variant as reported by Segata et al. (16).
LDA scores ranking differential taxa are displayed on a LEfSe bar
chart according to their effect size. For LEfSe analysis data are
first converted to log10 before the non-parametric Kruskal-Wallis
rank sum test. A significant alpha level of 0.05 and an effect
size threshold of a three times greater difference was used for
displaying results in this study.

Although all animals were fed the same diets with no differences
in energy intake as shown by end of phase 2, OP rats gained
more body weight, had higher fat accretion (P < 0.0001) in
both phases 1 and 2 compared to the OR rats. During phase
1 (1st 4 weeks), all animals were fed a HF diet. Phase 2 (2nd
4 weeks) began after the microbiota transplant between the
OP or OR rats and then the rats were switched to a HF diet
containing RS. The OP rats had higher body weight, abdominal
fat weight and EBW compared to OR rats. The knockdown
type and transplant had no effect on body weight, abdominal
fat weight and EBW (Tables 2, 3). The OR rats given the NA
treatment had lower abdominal fat than other groups among
OR. The pH and quantity of SCFAs in cecal contents were not
determined in phase 1 because all the cecal contents from the
rats euthanized were used for the transplant. In phase 2 after
the knockdown and transplant and including resistant starch in
the diet, the empty cecum weight, and total amount of SCFAs
(acetate, butyrate, and propionate) were higher in OP rats while
pH of the cecal contents was lower in OP rats (Tables 2, 3). Only
phenotype impacted the amounts of SCFAs, pH of cecal contents
and weight of the cecum reflecting higher fermentation in OP
rats (Table 3). The transplant after treatment with antibiotics or
MiraLAX had no effects on fermentation parameters compared
to the water controls in both OP and OR rats (Table 3). After the
robust fermentation of RS in OP rats during Phase 2, they had
relatively higher amounts of total bacteria compared to OR rats
which had modest fermentation as determined by quantifying the
16S rRNA gene (Tables 2, 3; P < 0.05; n = 6). The rats from either
phenotype had greater amounts of bacteria with the MiraLAX R
knockdown treatment.

PICRUSt2
To predict the metabolic pathways, phylogenetic investigation of
communities by reconstruction of unobserved states (PICRUSt2)
was performed from sequencing data, as shown before (17).
Fastq sequence files for each sample were processed using
QIIME2. Representative sequences were used as input files for the
PICRUSt2 analysis pipeline. Metabolic pathways were assigned
based on the Kyoto Encyclopedia of Genes and Genomes
(KEGG) Ortholog (KO) database. Read abundance data for
all predicted pathways were converted to relative abundance
(%) and by the Galaxy server (https://huttenhower.sph.harvard.
edu/galaxy/) for LEfSe analysis using LDA score 3.0 as a
threshold level to determine pathways taxa most likely to explain
differences between the OP and OR rats.

Statistical Analyses

Bacterial Diversity Metrics

Data for phase 1 were analyzed by t-tests in SAS 9.4 by the PROC
TTEST. At the end of the study, phase 2 data were analyzed in
SAS 9.4 by the PROC TTEST to compare effects of phenotype
(OP vs. OR while the effects of the treatments (VM, NA, LX,
WA) were compared by PROC GLM test (SAS Institute, Cary,
North Carolina). Effects of the knockdown treatments and of the
transplant were compared to those of the water control. Main and
interactive effects were considered significant at P < 0.05 and
expressed as means ± SE. Further tests were performed using
the Tukey’s test of multiple comparisons. Data were analyzed
for outliers using studentized residuals. Statistical significance for

Frontiers in Nutrition | www.frontiersin.org

Alpha-Rarefaction
The rarefaction curves for all rats reached a plateau
indicating that the sequencing depth was sufficient to
detect majority of ASVs in each sample and capture the
microbial diversity (Supplementary Figure 1). Rarefaction
curves comparing phenotype indicate that the microbiota
of OR rats had higher richness (more ASVs) compared
to OP rats (Figure 2A) regardless of sequencing depth.
Faith-pd which takes phylogenetic distance into account
and is confounded by richness was also higher in OR rats
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TABLE 2 | Body weight, Body fat, and Fermentation variables at the end of Phase 1.
OP means (SE)

OR means (SE)

P-value after T-Test

Energy intake (Kcal/d)

81.95 (0.76)

78.17 (1.07)

ns

Body weight (g)

378.1 (13.2)

303.1 (8.47)

<0.01

EBW (g)

369.4 (10.3)

292.01 (8.2)

<0.01

Abdominal fat (g)

18.9 (1.29)

10.8 (0.70)

<0.001

Full cecum weight (g)

2.74 (0.51)

2.56 (0.73)

ns

Empty cecum weight (g)

0.70 (0.13)

0.73 (0.04)

ns

Total SCFAs (g)

–

–

–

pH of cecal contents

–

–

–

1.04 (0.04)

1.64 (0.24)

<0.01

Total Bacteria per g fecal sample (X 109 gene copies of 16S gene)

TABLE 3 | Body weight, Body fat, and Fermentation variables at the end of Phase 2.
OP means (SE)

VA
Energy intake Kcal/d)

NA

OR means (SE)

LX

WA

VA

NA

P-value
After ANOVA

LX

WA

83.4 (4.01)

76.2 (3.08)

74.6 (1.62)

78.1 (3.62)

77.6 (1.89)

74.1 (2.87)

78.0 (1.92)

77.0 (1.18)

ns

Body weight (g)

477.3 (11.3)a

470.4 (13.9)a

454.5 (16.3)a

460.8 (19.5)a

371.7 (13.4)b

360.1 (11.0)b

359.8 (6.01)b

361.9 (5.72)b

<0.001

EBW (g)

464.8 (27.6)a

456.9 (33.6)a

445.8 (50.0)a

448.8 (47.1)a

370.1 (31.7)b

351.2 (25.6)b

359.8 (15.5)b

a

Abdominal fat (g)

26.4 (1.77)

Full Cecum weight (g)

12.3 (0.67)a

Empty Cecum weight (g)

1.36 (0.07)

a

26.2 (2.13)

a

12.2 (1.48)a
1.28 (0.1)

a

25.1 (3.54)

a

11.76 (1.35)a
1.43 (0.12)

a

26.3 (3.94)

a

12.64 (1.51)a
1.51 (0.20)

a

11.2 (1.90)

b

8.35 (1.17)

c

10.6 (1.61)

359.9 (16.6)b

<0.001

b

9.84 (3.94)b

<0.001

3.36 (0.19)b

3.62 (0.28)b

3.19 (0.25)b

3.80 (0.64)b

<0.001

b

b

b

0.85 (0.07)b

<0.001
<0.001

0.75 (0.03)

0.87 (0.07)

0.83 (0.06)

Total SCFAs (nmole/cecum)

0.59 (0.06)a

0.87 (0.04)a

0.65 (0.04)a

0.61 (0.03)a

0.10 (0.01)b

0.15 (0.01)b

0.12 (0.01)b

0.14 (0.02)b

pH of cecal contents

5.64 (0.8)a

5.78 (0.1)a

5.65 (0.2)a

5.89 (0.23)a

6.9 (0.12)b

7.2 (0.24)b

6.8 (0.56)b

6.9 (0.21)b

0.005

Total Bacteria per g cecal
samples (X 108 gene copies
of 16S gene)

1.4 (0.03)a

1.1 (0.02)a

1.6 (0.04)b

1.0 (0.03)a

0.73 (0.03)c

0.72 (0.006)c

1.09 (0.03)a

0.66 (0.01)c

<0.01

VA, Vancomycin; NA, Neomycin and Ampicillin; LX, MiraLAX®; WA, Water; EBW, Embowelled body weight. P-value is for overall test (ANOVA), Different letters indicate significant
differences after Tukey’s test of multiple comparisons.

OR compared to OP rats was mainly observed in the NA and
VM antibiotic treated rats. Analysis based on transplant method
did not show differences between the control water transplant
and the microbiota transplant in both OP and OR rats. The
comparison between knockdown treatments and the transplant
was made on the recovered microbiota (4 weeks after antibiotics,
MiraLAX R or water treatment). Evenness as measured by the
Pielou’s index was higher in all OR rats compared to OP
rats irrespective of knockdown and transplant. While evenness
was lower in OP rats treated with water compared to those
treated by NA and VM and LX, evenness was not different
among all OR rats irrespective of knockdown or transplant
(Figure 3F).

(Figure 2B). The asymptotic shape of the curves in both
indices indicate that a moderate sequencing depth (ca. 10,000)
was sufficient to capture the majority of the diversity in
each group.

Alpha Diversity and Evenness Measures
The composition of the microbiota and alpha and beta diversity
was compared based on phenotype (OP vs. OR rats), based
on knockdown method (VM, NA, LX, or WA control) and
also based on the microbiota transplant outcome between the
two phenotypes compared to the WA control transplant. The
microbiota of OR rats had significantly higher alpha diversity
with number of ASVs, Faith pd, Pielou-e measure of evenness,
and Shannon indices showing significantly higher values than
those of OP rats (P < 0.001) (Figures 3A–D). Further analysis
showed that the diversity in OP and OR rats were not different
in rats treated with water as control knockdown treatment
(P = ns) but in antibiotic and MiraLAX R groups, OR rats also
had higher diversity (P < 0.05) (Figure 3E). The OR rats also
had higher diversity irrespective of the transplant (Figure 3F)
indicating that the knockdown treatment and transplant did not
change the microbiota. The relatively higher overall diversity in
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Beta Diversity Measures
The multiway Adonis test for effects of phenotype gave an R2 value of 0.155 and P < 0.001 indicating that 15.5% of the
variation in distances is explained by phenotype. Adonis test
for effects of knockdown gave an R2 -value of 0.088 indicating
a smaller but significant effect size of 8% (P = 0.032). The
interaction of phenotype and knockdown had an R2 of 0.088
and P = 0.036. The Adonis test measures differentiation among
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FIGURE 2 | Rarefaction curves on samples obtained after phase 2. (A) Rarefaction based on the number of sequence variants showed richness was higher in OR
rats. (B) Rarefaction based on Faith-Pd showed that phylogenetic distance was higher in OR rats. In both cases n = 24.

FIGURE 3 | OR rats had a higher alpha diversity and eveness irrespective of the transplant. (A–D) Number of ASVs, Faith-pd, Shannon, Pielou-e indices were all
higher in OR rats (P < 0.001;n = 6). (E) In rats treated with VM, NA and LX before the transplant, the number of ASVs were significantly higher in OR rats compared to
OP rats (P < 0.02) but in rats treated with water there was no difference between OP and OR. T/LX in OP vs. T/LX in OR: P < 0.05; T/NA I OP vs. T/NA in OR:
p = 0.02; T/VM I OPvs. T/VM in OR: p = 0.014. T/WA in OP vs. T/WA in OR: p = 0.8. Among OR rats, those treated with NA had lower diversity (P < 0.05). In all
cases n = 6. (F) Pielou-e eveness index was lower in OP rats treated with WA control compared to those treated with antibiotics and LX. It was not different among all
treatments in OR rats. Overall OR rats had significantly higher eveness compared to OP rats irrespective of the knockdown and transplant treatment (T/NA in OP vs.
T/NA in OR: P < 0.004, T/VM in OP vs. T/VM in OR: p = 0.014; T/WA in OP vs. T/Wain OR: p = 0.015; T/LX in OP vs. T/LX in OR: P < 0.03). In all cases n = 6.
Different letters indicate significant differences after a T-test or Tukey’s test of multiple comparisons.

knockdown transplant (pseudo-F = 1.15; P = 0.25 and F = 1.66;
P = 0.22, respectively; weighted unifrac Permdisp (Figure 4).
We performed additional pairwise tests for differentiation
in centroid location, i.e., the mean position of all the samples

microbiota based on location and spread of samples defined
by their community similarity in the multivariate space. No
significant differences in within group variation (dispersion) of
bacteria community similarities were detected for phenotype or
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FIGURE 4 | Permdisp to assess beta diversity. The first boxplot in each figure is the intra group variability, all others are inter-group variability. (A) No significant
differences between OP and OR phenotypes (pseudo-F = 1.15; P = 0.25 n = the number of pairwise comparisons as shown on x-axis. (B) Significance of the
distance to OR rats treated with water as knockdown and transplant from all other knockdown-transplant treatments (ns, not significant) (s, significant) (P < 0.05 after
the number of pairwise comparisons shown on x-axis (n). Significant differences were based only on phenotypes (pseudo-F = 1.74 P = 0.02). (C) Significance of the
distance to OP rats treated with water as knockdown and transplant from all other knockdown-transplant treatments (ns, not significant) (s, significant) (P < 0.05 after
the number of pairwise comparisons shown on x-axis (n). Significant differences were based only on phenotypes (pseudo-F = 1.66 P = 0.22).

The patterns observed in the alpha and beta diversity analysis
were confirmed after taxonomic assignments as more taxonomic
groups were observed in OR rats albeit at very low amounts e.g.,
Class Deferribacteres (Figure 6).

within each group (Permanova). The one-way Permanova nonparametric test of significant difference between groups, based on
weighted unifrac distance showed significant differences between
OP and OR bacteria composition (pseudo-F = 27.6; P < 0.001).
Calculated distances among the OP group, within the OR group
and between OP and OR are shown in Figure 5. Figures 5A,B,
visualizes them in the PCA plot. Calculated distances for
knockdown treatments based on distance from the control
water treated rats (WA) (Figures 5C–E). showed significant
differences (pseudo-F = 5.34; P < 0.001) between microbiota
composition based on phenotypes but not knockdown treatment.
Tests based on transplant also showed significant differences
(pseudo-F = 10.54; P < 0.001) between microbiota composition
by phenotype but not transplant. The PCA plots shown in
Figures 5A,B show that group separation was all based on only
phenotype while knock down and transplant did not result in
group separation except for one OR rat treated with LX which
grouped with OP rats.

Firmicutes
Qualitative analysis showed that at phylum level, OR rats
had higher relative proportions of Firmicutes; 62.2% in OR
rats while OP had 32.6%. Among classes in this phylum OR
rats had higher amounts of Clostridia and Bacilli, 40.1 and
10.8%, compared to 17.6 and 3.9% for OP rats, respectively.
Proportions of class Erysipelotrichi were similar between OP
and OR rats at 13 and 14%, respectively. Breaking down
the data at order levels revealed that class Clostridia was
composed entirely of order Clostridiales in both OP and OR
rats. Class Bacilli was composed of order Lactobacillales and
Turicibacterales with OR rats having 9.2 and 1.6%, compared to
OP 3.9 and 0.02%, respectively. Families in the order Clostridiales
were Clostridiaceae, Lachnospiraceae, Peptococcaceae, and
Peptostreptococcaceae. The only family among Firmicutes that
was higher in OP rats was Ruminococcaceae at 3.6% in OP
compared to 0.7% in OR rats. All other Clostridiales families were
present in higher proportions in OR rats. The major difference
in proportions was in Clostridiaceae where OR rats had 14.2%
compared to OP rats at 0.47%. Lachnospiraceae abundance was
higher in OR (26.0%) compared to OP (17.4%). Clostridiaceae

Comparative Analysis of the Gut
Microbiota Taxa Composition
Relative abundances of bacterial taxa after feeding the rats
a HFRS were compared based on phenotype (OP vs. OR
rats), based on knockdown method (VM, NA, LX, or WA)
and also based on the transplant outcome between the two
phenotypes compared to the water control transplant (Figure 6).
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FIGURE 5 | Permanova and PCA plots to assess beta diversity. The first boxplot in each figure is the intra group variability, all others are inter-group variability.
Distances represent similarity of the microbial composition between the samples: (A) Distances based on phenotype OP vs. OR (n = 24). (B) Knock down and
transplant treatment (T) did not result in group separation other than by phenotype (n = 6). (Example: T after VM: means Transplant with microbiota of opposite
phenotype after knockdown with VM). Data points represents the distribution of principal components in 3 different directions and the closer the data points, the
closer the relationship between the samples. (C) Significant differences between OP and OR (pseudo-F = 27.6; P = 0.001 after 399 pairwise comparisons. (D)
Significance of the distance to OR control rats treated with water from all other knockdown-transplant treatments (pseudo-F = 5.34; P = 0.001 (ns, not significant) (s,
significant) (P < 0.05 after the number of pairwise comparisons shown on x-axis (n). (E) Significance of the distance to OP control rats treated with water from all other
knockdown treatments (pseudo-F = 5.34; P = 0.001 (ns, not significant) (s, significant) (P < 0.05 after the permutations shown on x-axis. (ns, not significant)
(s,significant) (P < 0.05) after the number of pairwise comparisons shown on x-axis (n).

Bacteroidetes

was composed mainly of Clostridium cluster I; Clostridium sensu
stricto at 8.71% in OR rats while it ranged from 0 to 0.03% in
OP rats. Class Bacilli was comprised of families Lactobacillaceae
and Streptococcaceae and Enterococcaceae. OR rats had higher
proportion of Lactobacillaceae and Streptococcaceae both at
6.94 and 2.2% respectively while OP rats had 3.15 and 0.7%
respectively (Figure 6).

The phylum Bacteroidetes consisted solely of the class
Bacteroidia and order Bacteroidales and was represented
by over twice the abundance in OP rats at 47.8% while OR
rats had 21.4%. Each of the families under this phylum, i.e.,
Bacteroidaceae, Muribaculaceae (S24-7), Rikenellaceae and
Porphyromonadaceae were present in higher proportions in
OP rats compared to OR rats. Specifically, OP rats had 21.9%
Muribaculaceae while OR rats had 7.3%. The OP rats had 12.5%
Bacteroidaceae while OR had 8.8%. Families Rikenellaceae and
Porphyromonadaceae were present in much lower proportion in
both OP and OR (Figure 6).

Verrucomicrobia
The phylum Verrucomicrobia contained only a single
uncultured Akkermansia species (class Verrucomicrobiae,
order Verrucomicrobiales family Verrucomicrobiaceae) with
3.55% abundance in OR rats and 0.27% in OP rats. It was notable
that OR rats treated with NA antibiotic had lower alpha diversity
(Figure 3E) compared to OR rats treated with VM antibiotic,
LX and WA. These NA treated rats had no Verrucomicrobia
detected but instead had higher amounts of class Coriobacteriia
(phylum Actinobacteria) compared to those treated with WA,
LX, and VM (Figure 6).
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Actinobacteria
The OP rats had 15.5% of their bacteria in phylum Actinobacteria
while OR rats had 6.5%. Classes among this phylum were
Actinobacteria (12.1% in OP vs. 4.2% in OR) and Coriobacteriia
(3.4% in OP vs. 2.2% in OR). Class Actinobacteria comprised
of order Actinomycetales (0.7% in OP vs. 0.2% OR) and
Bifidobacteriales (12.1% in OP vs. 3.8% in OR). Class
Coriobacteriia was comprised entirely of order Coriobacteriales.
Families in this phylum were Bifidobacteriaceae (12% in OP and
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FIGURE 6 | The relative abundance of bacterial groups depended only on rat phenotype but not knockdown method or the transplant. 16S sequencing data showed
that the knockdown and transplant did not change the proportions of taxa between the OP and OR phenotypes. In all cases n = 6. (A) OR rats had higher amounts of
phylum Firmicutes and Verrucomicrobia while OP rats had higher Bacteroidetes, Actinobacteria, and Proteobacteria. (B) OR rats had higher amounts of Clostridia,
Bacilli, and Verrucomicrobiae while OP rats had higher Bacteroidia, Actinobacteria, Coriobacteria, and Betaproteobacteria. (C) OR rats had higher amounts of orders
Clostridiales, Lactobacillales, Verrucomicrobiales, and Turicibacterales while OP had higher amounts of Bacteroidales, Bifidobacteriales, and Burkholderiales.
Erysipelotrichi/order Erysipelotrichales was not different between OP and OR rats. (D) OR rats had higher amounts of families Lachnospiraceae, Clostridiaceae,
Lactobacillaceae, Turicibacteraceae, Peptostreptococcaceae, and Verrucomicrobiaceae while OP had higher Bacteroidaceae, Muribaculaceae (S24-7),
Bifidobacteriaceae, Alcaligenaceae, and Ruminococcaceae.

LDA score, the abundance of 74 taxa were different between
the OP and OR rats and accounted for discriminative features
between the rats (Figures 7A,B). A p < 0.05 was considered
significant in a non-parametric Kruskal-Wallis rank sum test.
The LEfSe output was in agreement with abundances shown
in the qualitative plots of taxa abundances (Figure 6) showing
that order Clostridiales specifically families Clostridiaceae and
Lachnospiraceae were most abundant in OR rats while families
Bacteroidaceae and Muribaculaceae were most abundant in
OP rats.

3.8% in OR), Coriobacteriaceae (3.2% in OP and 1.2% in OR) and
Micrococcaceae at much lower proportions (Figure 6).

Proteobacteria
Bacteria from phylum Proteobacteria were present at similar
proportions in OP and OR rats; 3.5% in OR and 3.8% in
OP. However, at class level, Betaproteobacteria was higher
in OP at 2.7% compared to 1.3% in OR while class
Gammaprotobacteria was lower in OP at 1.7% compared to
2.7% in OR. Betaproteobacteria was comprised entirely of
order Burkholderiales with only family Alcaligenaceae detected.
Gammaprotobacteria was composed of order Enterobacteriales
with only family Enterobacteriaceae detected (Figure 6).

Correlation Between ECW, Alpha Diversity,
and Abundance in Specific Taxa
The empty cecum weight (ECW) is a marker of fermentation
levels in the cecum and was significantly higher in OP rats
compared to OR rats after including RS in the diet (P < 0.001)
(Table 3). We first performed Spearman correlations between
ECW and measures of alpha diversity and evenness. ECW
negatively correlated with the alpha diversity measures: Shannon
index (ρ = −0.61; P < 0.001), Number of ASVs (ρ = −0.54;
P < 0.001), Faith-pd (ρ = −0.51; P = 0.001), and Pielou-e

Linear Discriminant Analysis Effect Size
(LEfSe)
The LEfSe algorithm was used to identify the key bacterial
taxa that account for the differences between the OP and
OR phenotypes. LEfSe estimates the effect size of significantly
different abundances of taxa and ranks them represented by the
length of each bar (16). At a threshold of 3.0 on the logarithmic
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FIGURE 7 | Linear discriminant analysis. (A) Differential abundance of taxa was ranked according to their effect size between OP and OR rats. Selection of
discriminative taxa between groups were based on an LDA score cutoff of 3.0 and differences in the relative abundances of taxa (converted to log base 10) were
statistically determined based on a Kruskal–Wallis and pairwise Wilcoxon tests. A p-value of < 0.05 and a score ≥ 3.0 were considered significant in Kruskal–Wallis
and pairwise Wilcoxon tests, respectively, at a significance level of 0.05; n = 24. The length of the histogram represents the LDA score; i.e., the degree of influence of
species with significant difference between different groups. (B) The red or green shading depicts bacterial taxa that were significantly more abundant in either the OP
or OR groups, respectively. The yellow circles on the cladogram depict bacterial taxa that were not significantly different or changed. Selection of discriminative taxa
between groups were based on an LDA score cutoff of 3.0.

relative abundance and differences between diets are presented
in Figure 9. LEfSe analysis at a 3.0 threshold level and at a pvalue of 0.05 in a non-parametric Kruskal-Wallis rank sum test
showed that 38 pathways accounted for discriminative features
between the OP and OR rats (Figure 9A). The top 5 pathways
significantly higher in the microbiota of OR rats were the
bacterial chemotaxis pathway, the phosphotransferase system
(PTS), fatty acid biosynthesis, sulfur relay system and D-alanine
metabolism. On the other hand the microbiota of OP rats had
higher levels of C5-branched dibasic metabolism, vitamin B6
metabolism, lipoic acid metabolism, other glycan metabolism,
and lipopolysaccharide (LPS) synthesis. The predicted microbial
pathways in OP and OR rats clustered differently after PCA
analysis (Figure 9B). Figure 9C shows the visual correlation of
amount of SCFAs and body fat with microbial functions.

index (ρ = −0.56; P < 0.002) (Supplementary Figure 2). Higher
fermentation was thus associated with lower alpha diversity.
We next performed correlations between ECW and taxa
groups with differential abundance as identified by LefSE.
ECW significantly negatively correlated with bacterial
taxa that were more abundant in OR rats i.e., the family
Clostridiaceae (R2 = −0.53), genus Clostridium sensu stricto 1
(R2 = −0.54), genus Clostridium sensu stricto (other species)
(R2 = −0.51), genus Faecalibaculum (R2 = −0.38). A weaker
negative correlation was observed between other taxa among
Firmicutes including families Peptostreptococcaceae (R2 =
−0.16), Lactobacillaceae (R2 = −0.21) and Lachnospiraceae
(R2 = −0.25). The genus Akkermansia also correlated with
R2 = −0.21 (all at P < 0.05; Figure 8). On the other hand, ECW
correlated positively with the taxa that increased with greater
fermentation i.e., family Muribaculaceae (R2 = 0.31) and genus
Bifidobacterium (R2 = 0.2). Only correlations with an R2 over ±
0.15 are shown in Figure 8. In summary a lean phenotype was
associated with abundance of members of class Clostridia and
genus Akkermansia.

DISCUSSION
Because all rats were fed the same diets, this study focused on
links between the microbiota rather than diet exposure to the
development of obesity. Including both OR and OP rats enabled
us to explore a possible link between gut microbiota composition
and development of obesity when placed on a high calorie diet
and in response to a diet supplemented with resistant starch.

Predicted Metabolic Functions
PICRUSt2 predicted a total of 152 functional pathways by
comparing against KEGG orthologs. Data were transformed to
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FIGURE 8 | Pearson correlation between ECW and relative abundance of particular taxa. (A) ECW negatively correlated with the abundance of family Clostridiaceae
(R2 = −0.55; P < 0.001). (B,C) Genera under Clostridiaceae Clostridium sensu stricto 1 and other species in this genus negatively correlated with ECW with R2 of
−0.51 and 0.54; P < 0.001). (D) Genus Faecalibaculum negatively correlated with ECW with an R2 of −0.38; P < 0.001. (E–G) Families Peptostreptococcaceae,
Lactobacillaceae, Lachnospiraceae negatively correlated with ECW with R2 ranging from −0.16 to −0.25; P < 0.01. (H) Family Muribaculaceae positively correlated
with ECW with R2 of 0.31; P < 0.001. (I) The positive correlation with genus Bifidobacterium had an R2 of 0.20; P < 0.001. (J) Akkermansia uncultured sp. negatively
correlated with ECW with R2 of 0.21; P < 0.001. Different letters indicate significant differences after a T-tests.
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FIGURE 9 | PICRUSt2 Analysis Predicted metabolic pathways by PICRUSt2 using 16s rRNA gene sequences. The pathways were predicted from the Kyoto
Encyclopedia of Genes and Genomes (KEGG) Ortholog (KO) database. (A) Linear discriminant analysis of predicted microbial metabolic functions between OP and
OR rats. Selection of discriminative microbial pathways between groups were based on an LDA score cutoff of 3.0 and differences in the relative abundances of
pathway (converted to log base 10) were statistically determined based on a Kruskal-Wallis and pairwise Wilcoxon tests. A p-value of < 0.05 and a score ≥ 3.0 were
considered significant in Kruskal-Wallis and pairwise Wilcoxon tests, respectively at a significance level of 0.05; n = 24. The length of the histogram represents the
LDA score; i.e., the degree of influence of species with significant difference between different groups. (B) PCA plots to assess beta diversity among the predicted
microbial metabolic functions between OP and OR rats. (C) Correlation of SCFAs, body fat and major microbial pathways.

confirmed 2 days after the antibiotic regime by qPCR of the 16S
gene. The aim was to switch gut microbiota via transplant to
increase fermentation in OR rats and decrease it in OP rats to
see if the greater obesity would still occur for OP rats. However,
there was no change in the difference between the OP and OR
rats for fermentation after the transplant. We did not evaluate
host genotype or epigenetic differences in this study but it is likely
that host genotype dominates diet in shaping the microbiota of
these rats. We included MiraLAX in the knockdown treatments
to investigate its potential compared to antibiotics which have
negative off target effects. However, MiraLAX did not sufficiently
knock down the microbiota and effects were not different from
that of the water treated control. Analysis of predicted metabolic
pathways in gut microbiota revealed that in OP rats the LPS
synthesis and glycan degradation pathways were higher than in
OR rats and may account for differences in phenotype.
It is possible that the brief exposure of cecal contents to
air during collection may have killed strict anaerobic bacterial
species and the surviving facultative anaerobic and aerotolerant bacteria species were not enough to elicit a change
in fermentation and lead to a change in accrual of abdominal
fat after the transplant. Strict anaerobes play a major role in
fermentation and microbiota transplants have been shown to be
successful. Satokari et al. (20) used a quick collection of fecal

Our results in this study and our previous study (5)
demonstrated that when placed on a HF diet OR remain leaner
compared to OP rats. We had hypothesized that OR rats
would ferment RS to a greater extent than OP rats because
our previous research demonstrated that through promotion of
fatty acid oxidation rodents fed RS accumulated less abdominal
fat compared to those fed the control diet (18, 19). While
the results of the current study appear to indicate that greater
fermentation is associated with greater obesity, our previous
study in which we compared different diets within the two
phenotypes, demonstrated that fermentation did not increase
abdominal fat compared to a group fed the same diet without
RS (with fully digestible starch) (5). Therefore, enhanced
fermentation in OP rats does not appear to be a contributing
factor to obesity in these rats. We further hypothesized that the
difference in susceptibility to accrual of body fat between OP and
OR rats may be attributed to the differences in gut microbiota
and their predicted metabolic pathways rather than the ability to
ferment. Mechanisms attributed to differences in the microbiota
would likely have to overcome the effect of increased fat oxidation
stimulated by increased fermentation. To test these in the current
study, we used a successful knockdown of the bacteria prior
to a transplant of the cecal contents between the OP and OR
rats. Reduction in bacterial load after antibiotic treatment was
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Maintenance of the diversity and collective functional capacity
of the bacteria that form the microbiota is vital for optimal
metabolic health throughout life. The microbiota of OR rats had
overall higher alpha diversity and evenness compared to OP
rats (Figures 1, 2) and there was a distinct separation between
the microbiota of OR rats and those of OP rats (Beta diversity)
(Figures 3–5). Generally, persons and animal models whose
microbiota has low gene richness (low bacterial diversity) are
more likely to be obese (19, 26) while higher diversity is associated
with better health outcomes. We previously observed higher
alpha diversity (richness and evenness) in obese ZDF rats fed
a control diet with no RS compared to obese ZDF rats fed RS.
Lower alpha diversity is a normal and healthy response with
the feeding of a relatively high amount of a fermentable fiber.
The lower diversity and evenness is due to the enrichment of a
subset of bacterial taxa that can efficiently adapt to metabolize the
RS polysaccharides and/or degradation products (19, 26). With
lower amounts of fermentation, the OR rats had a higher alpha
diversity in their gut microbiota. OR rats had a greater abundance
of bacteria from phylum Firmicutes specifically Clostridia with
family Clostridiaceae and Lachnospiraceae accounting for most
differences between OP and OR rats. It was notable that bacteria
of the family Clostridiaceae which all belonged to the genus
Clostridium sensu stricto were not detected in the OP rats
but were detected and abundant in OR rats (about 9% of the
microbiota) (Figures 6–8). Thus, abundance of Clostridiaceae
and Lachnospiraceae were not impacted by dietary RS or
its fermentation. The higher representation of Clostridia was
accompanied by higher alpha diversity. Members of Clostridia
are linked to enhanced immune function. They enhance the
development and function of intestinal regulatory T cells
(Treg cells) and T follicular helper cells. Treg cells in the
intestinal mucosa maintain homeostasis (28–32) and produce
large amounts of the anti-inflammatory cytokine IL-10 and
protect against obesity, tissue inflammation (32). While previous
studies have associated a higher Firmicutes to Bacteroidetes ratio
with obesity, our study shows otherwise. The OR rats which had
much higher abundance of Firmicutes and therefore a higher
Firmicutes to Bacteroidetes ratio, were leaner.
Verrucomicrobia consisting entirely of mucin degrading
Akkermansia sp. was much more abundant in OR rats; 3.6%
in OR rats while OP had 0.3%. The LDA analysis confirmed
differentially higher amounts in OR rats and accounts for
differences in the two phenotypes. Furthermore, abundance
of Akkermansia sp. inversely correlated with body weight
and an improved metabolic profile. However, it is notable
that among OR rats, those treated with NA antibiotic had
no Verrucomicrobia detected and had much lower alpha
diversity compared to the OR rats treated with VM, LX
and WA (Figures 3E, 6). These NA treated rats instead had
higher abundance of Coriobacteriia. Akkermansia sp. is usually
abundant in healthy guts and has been shown to be important
in maintaining intestinal integrity and attenuate high-fat diet
induced obesity and metabolic syndrome (33–36).
To investigate the relationship between obesity and gut
microbiome functions, we predicted the potential metagenomes
from the community profiles of 16S rRNA genes using PICRUSt2.

samples to spare strict anaerobes for fecal microbiota transplants
(FMT) to treat patients with an overgrowth of pathogenic C.
difficile bacteria and had a 96% efficacy rate. In another study,
Youngster et al. (21) used an aerobic collection procedure and
had a 70% efficacy rate. Phenotypic characteristics have been
observed to be transferrable in conventionalized rodents after a
microbiota transplant under both anaerobic and non-anaerobic
conditions (22, 23). The rats in our study were adults at the time
of the transplant. In mice it has been shown that the appropriate
time-window to perform successful microbiota transfer using
non-germ-free animals is shortly after weaning (24). However,
a microbiota transplant may be required or found useful at any
period of the lifetime to improve microbiota health.
Our conclusion is, the different amounts of bacterial types
from one rat phenotype were not as compatible with the genetics
and subsequent physiological environment in the GI tract of
the different phenotype despite the successful knockdown of
bacteria by the two antibiotic cocktails. It is possible that there
was resistance to new types of bacteria transplanted from one
type of rat phenotype to the other. It appears that once the
antibiotic cocktails were completed in the current study, and
rats were placed on the diet containing RS, bacterial types were
replenished to pre-antibiotic amounts. This is supported by the
fact that the difference in fermentation levels between OP and
OR were similar to those observed in our previous study (5) that
had no knockdown or transplant. In agreement with observations
from previous studies (5, 10) robust fermentation of RS was
accompanied with increases in Bacteroidetes particularly family
Muribaculaceae (S24-7) (5, 10) and Bifidobacterium (23, 25).
Muribaculaceae is a member of order Bacteroidales and bacteria
in this order are fermentative, but also possess alternative modes
of energy production. Carbohydrate-active enzymes constitute
about 6% of the Muribaculaceae coding sequences and based
on enzyme abundance, the genes encode glycoside hydrolases,
largely α-amylases, suggesting starch as a key substrate with
the ability to ferment several carbohydrate moieties (24–27).
Amounts of Muribaculaculaceae in OP rats were more than
double the amounts in OR rats after consumption of RS. This
may be an indicator that the GI tract environment of OR rats,
both host and microbiota combination, limits the amount of
Muribaculaceae (S24-7) and the amount of fermentation.
In agreement with several other studies that show
Bifidobacterium is enriched during RS interventions (24, 25),
OP rats had 14.2% Bifidobacterium while OR rats had 4.5%
(Figures 6, 8). While Bifidobacterium longum was the
only species identified in our study, other research works
in which Bifidobacterium was identified at the species
level showed that Bifidobacterium adolescentis is the most
frequently enriched species with feeding of RS2. It is a
primary RS2 degrader, as indicated by its growth on RS2
as a sole carbon source and the ability to adhere directly
to α1, 4–linked glucose units within starch granules. These
physical interactions likely provide a protective barrier that
may explain why RS increases the survival of amylolytic
Bifidobacteria in the GI tract (24, 25). The differential increase in
Muribaculaceae and Bifidobacterium lowered alpha diversity in
OP rats.
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than 1,000 fecal samples obtained from the TwinsUK population
and identified many microbial taxa whose abundances were
influenced by host genetics. In a study using eight genetically
distinct inbred mouse strains obtained from the same facility and
subjected to the same environmental conditions, Krezner et al.
(43) showed that the response to a high-fat/high-sucrose diet, was
dependent on genetic variance and that host genetics regulated
the composition of the microbiota.
In summary, we sought to determine whether a gut
microbiota transplant between the OP and OR rats can result
in a phenotype change based on acquisition of a changed
microbiota. The transplant did not change the microbial
composition or phenotype of the OP and OR rats. Based
on the current and a previous study with OP and OR rats,
other host-microbiota mechanisms besides fermentation may
promote their different phenotypes. In addition to microbiota
composition, genetic or epigenetic differences between the rats
may play a major role in the ultimate phenotype of these
rats. The most significant difference in microbiota composition
that may promote resistance to obesity in OR rats was
the higher representation of the families Clostridiaceae and
Lachnospiraceae and genus Akkermansia and the higher alpha
diversity. In addition, the different bacterial compositions
precipitated in differences in the predicted microbial pathways
that may account for the different phenotypes. These predicted
pathways include chemotaxis, phosphotransferase system (PTS),
and fatty acid biosynthesis in OR rats and glycan metabolism
and LPS synthesis in OP rats. Because the microbiota
transplant did not result in significant changes in microbiota
composition or phenotype, we propose conducting a cohousing study between the two phenotypes as follow-up to
monitor microbiota composition and body weight over a specific
time frame.

The chemotaxis pathway was found to be differentially higher in
the microbiota of OR rats. Chemotaxis, a process transduced via
protein-protein interactions is a mechanism by which bacteria
efficiently and rapidly respond to changes in the chemical
composition of their environment toward chemically favorable
environments and avoid unfavorable environments. Bacteria
continuously monitor a spectrum of sensory inputs. While the
OP and OR rats were on the same diets, the sensory inputs
may differ in the intestinal environment after fermentation
and ultimately impact nutrient uptake and utilization by
the bacteria (37). While OR rats had much less SCFAs
detected in the intestinal contents, PICRUt2 analysis showed
that their fatty acid biosynthesis pathway was significantly
higher compared to OP rats. The primary role of bacterial
fatty acids is to act as the hydrophobic component of the
membrane lipids (phospholipids) and they are also components
of storage lipids e.g., polyhydroxyalkanoic acids in several
bacterial species (38). While the role of SCFAs in this process
is unclear, we found a negative correlation of SCFAs levels
with fatty acid biosynthesis pathway (Figures 9A–C). The
phosphotransferase system (PTS) a distinct method employed by
bacteria for sugar uptake and phosphorylation using energy from
phosphoenolpyruvate (PEP) was higher in the microbiota of
OR rats. Several monosaccharides, disaccharides, amino sugars,
polyols, and other sugar derivatives are consumed by this
process. PTS regulation network controls carbohydrate uptake
and metabolism and has numerous regulatory functions (39).
This may account for why starch and sucrose metabolism
pathway was differentially higher in the OR rats (Figure 9A).
The polysaccharide (LPS) synthesis, other glycan metabolism
and lipoic acid metabolism were significantly higher in the
microbiota of OP rats. Evidence has shown that LPS is involved
in the development of obesity as a direct targeting molecule
for lipid delivery and storage in adipose tissue and is involved
in inflammatory mechanisms (40). While the human genome
is capable of fully degrading a very small subset of glycans
that have only one or two different linkages i.e., starch, lactose
and sucrose, bacteria possess the corresponding enzymatic tools
for depolymerizing numerous glycans into their component
monosaccharides. Gut microorganisms vary widely in the
number of different glycans that they can target (41). It is
possible that the microbiota of OP rats degrades different types
of glycans including larger structures like the plant cell wall
or ubiquitously abundant dietary glycans, thus enhancing their
capacity to harvest more energy from the host diet and thus
promote host obesity. The enhanced lipoic acid metabolism
may be as a result of this enhanced glycan metabolism to
support energy production and the regulation of carbohydrate
and protein metabolism.
The role of host genetics on the obesity phenotype may
be greater than the role of the gut microbiota in these
rats. Furthermore, host genetics may impact gut microbiota
composition and thus explain why the transplant was not
successful. Other researchers have previously shown that
interactions between gut microbiota, host genetics, and diet
modulate the predisposition to obesity and metabolic phenotypes
(42–46). Goodrich et al. (42) compared microbiotas across more
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